Market revenue in 2023 | USD 2,699.7 million |
Market revenue in 2030 | USD 5,755.6 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 33.48% in 2023. Horizon Databook has segmented the Thailand personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
The Genomics Thailand Initiative, launched in 2019, aims to sequence 50,000 Thai individuals within five disease groups, including cancers, rare diseases, noncommunicable diseases, infectious diseases, and pharmacogenomics. Such initiatives are expected to support the growth of the personalized medicine market in Thailand.
In Thailand, constant developments in the field of cancer screening have positively impacted the market. For instance, in April 2022, Banphaeo General Hospital collaborated with AstraZeneca Thailand to launch the “Don’t Wait. Get Checked.” campaign, which integrated AI to diagnose early-stage lung cancer. This is anticipated to create further opportunities in the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into Thailand personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account